For the quarter ending December 31, 2024, the Strategy outperformed its benchmark, the Bloomberg U.S. Corporate Index (the ...

Equity market performance in the fourth quarter was in many ways a microcosm of the past two years. Read more here.

Enovis™ Corporation ("Enovis” or "the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and full year ended ...